Clinical trial
Effect of Personalized Hemodynamic Management Based on Serum Renin Concentration on Acute Kidney Injury Progression in Patients With Shock: a Randomized Controlled Trial.
NCT05898126 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Personalized Hemodynamic Management Based on Serum Renin Concentration on Acute Kidney Injury Progression in Patients With Shock: a Randomized Controlled Trial.
- Lead sponsor
- Università Vita-Salute San Raffaele
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 27, 2025
- Completion date
- July 28, 2027
- Enrollment
- 800 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.